Lords continue to call for clarity on ‘no-deal Brexit’ medicines access
As uncertainty remains on access to medicine in the event of a no-deal Brexit, Lords are continuing to call for clarity on the issue.
Read More
Tag: uncertainty
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
